Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer

International Journal of Hyperthermia

Volumn 30, Issue 3, 2014, Pages 176-183

  Juang, Titania ^a,b   Stauffer, Paul R ^b,c   Craciunescu, Oana A ^b   Maccarini, Paolo F ^b   Yuan, Yu ^b   Das, Shiva K ^b   Dewhirst, Mark W ^b   Inman, Brant A ^a   Vujaskovic, Zeljko ^b,d  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder cancer; Deep heating; Hyperthermia; Thermal dosimetry; Thermochemotherapy

Indexed keywords

MITOMYCIN;

ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; DOSIMETRY; EXTERNAL DEEP REGIONAL PELVIC HYPERTHERMIA; HEATING; HUMAN; HYPERTHERMIA; HYPERTHERMIC THERAPY; MAINTENANCE THERAPY; MALE; NON MUSCLE INVASIVE BLADDER CANCER; PRESCRIPTION; RADIOFREQUENCY; TEMPERATURE MEASUREMENT; THERMAL DOSIMETRY; THERMISTOR; THERMOMETRY; TREATMENT PLANNING; COMPUTER ASSISTED TOMOGRAPHY; PATIENT SATISFACTION; RADIOGRAPHY; TUMOR INVASION; URINARY BLADDER NEOPLASMS;

HUMANS; HYPERTHERMIA, INDUCED; NEOPLASM INVASIVENESS; PATIENT SATISFACTION; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER NEOPLASMS;

EID: 84899732111     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2014.898338     Document Type: Article

References (22)

1. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220-41.
2. Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-4.
3. Malmstrom PU, Sylvester RJ, Crawford DE, Friedrich M, Krege S, Rintala E, et al. An individual patient data meta-Analysis of the long-Term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscleinvasive bladder cancer. Eur Urol 2009;56:247-56.
4. Sylvester RJ, Van der Meijden AP, Witjes JA, Kurth K. Bacillus Calmette-Guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: A meta-Analysis of the published results of randomized clinical trials. J Urol 2005;174: 86-91; discussion 92.
5. Abern M, Owusu R, Anderson M, Rampersaud E, Inman B. Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: A systematic review and meta-Analysis. J Natl Compr Canc Netw 2013;11:477-84.
6. Davis JW, Sheth SI, Doviak MJ, Schellhammer PF. Superficial bladder carcinoma treated with bacillus Calmette-Guerin: Progression-free and disease specific survival with minimum 10-year followup. J Urol 2002;167:494-500; discussion 501.
7. Shahin O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE. A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: Recurrence, progression and survival. J Urol 2003; 169:96-100; discussion, p 100.
8. Dewhirst M, Das S, Stauffer P, Craciunescu O, Vujaskovic Z, Thrall D. Hyperthermia. In: Gunderson L, Tepper J, eds. Clinical Radiation Oncology, 3rd ed. Philadelphia, PA: Elsevier-Saunders; 2012. pp 385-403.
9. Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001;17:1-18.
10. Sneed PK, Stauffer PR, Li G, Sun X, Myerson R. Hyperthermia. In: Phillips T, Hoppe R, Roach M, eds. Textbook of Radiation Oncology, 3rd ed. Philadelphia, PA: Elsevier Saunders; 2010. pp 1564-93.
11. Colombo R, Da Pozzo LF, Salonia A, Rigatti P, Leib Z, Baniel J, et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 2003;21:4270-6.
12. Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, et al. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology 2004;63:466-71.
13. Lammers RJ, Witjes JA, Inman BA, Leibovitch I, Laufer M, Nativ O, et al. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscleinvasive bladder cancer: A systematic review. Eur Urol 2011;60: 81-93.
14. Acton QA. Bladder Cancer: New Insights for the Healthcare Professional: 2013 Edition: ScholarlyEditions, 2013. Available from http://books.google.com/ books?idUBx5eofbuJcC.
15. Oliveira T, Stauffer P, Lee K, Landon C, Wiguins E, Maccarini P, et al. Preclinical dosimetry of magnetic fluid hyperthermia for bladder cancer. Proc SPIE 2013;8584:1656985. doi:10.1117/ 12.2005623.
16. Oliveira T, Stauffer P, Lee C, Landon C, Etienne W, Ashcraft K, et al. Magnetic fluid hyperthermia for bladder cancer: A preclinical dosimetry study. Int J Hyperthermia 2013;29:835-44.
17. Inman BA, Stauffer PR, Craciunescu OA, Maccarini PF, Dewhirst MW, Vujaskovic Z. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia 2014;30:171-5.
18. Yuan Y, Cheng KS, Craciunescu OI, Stauffer PR, Maccarini PF, Arunachalam K, et al. Utility of treatment planning for thermochemotherapy treatment of nonmuscle invasive bladder carcinoma. Med Phys 2012;39:1170-81.
19. Van der Zee J, Gonzalez-Gonzalez D, Van Rhoon GC, Van Dijk JDP, Van Putten WLJ, Hart AAM. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Lancet 2000; 355:1119-25.
20. Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 2009;25:3-20.
21. Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 2003;19: 267-94.
22. Franckena M, Fatehi D, de Bruijne M, Canters RA, Van Norden Y, Mens JW, et al. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer 2009;45:1969-78.